5x107 cAG Intensity Report 0 0.00 2.00 4.00 6.00 8.00 10.00 12.00 14.00 16.00 Minutes 18.00 20.00 22.00 24.00 26.00 28.00 30.00 SampleName: P5000 HD 2051964; Vial: 43; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 8:40:38 AM CEST SampleName: P2000 LD 2124687; Vial: 42; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 8:09:30 AM CEST SampleName: H547; Vial: 16; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 7:38:07 AM CEST SampleName: H547; Vial: 15; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 7:06:58 AM CEST SampleName: H544; Vial: 14; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 6:35:49 AM CEST SampleName: MQ; Vial: 13; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 6:04:39 AM CEST SampleName: H539; Vial: 12; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 5:33:30 AM CEST SampleName: H538; Vial: 120; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 5:02:03 AM CEST SampleName: H537; Vial: 119; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 4:30:59 AM CEST SampleName: H536; Vial: 118; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 3:59:50 AM CEST SampleName: H535; Vial: 117; Injection: 1; Channel: QDa 3: SIR Ch1; Date Acquired: 7/13/2024 Component Summary Table Name: cAG SampleName Inj Channel Name RT Area Height Amount Units Vial 1 S0.1 1 QDa 3: SIR Ch1 cAG 4.887 2 mQ 1 QDa 3: SIR Ch1 cAG 5.058 483275 64961 1 3 mQ 2 QDa 3: SIR Ch1 cAG 4.963 331969 57891 1 4 S0.5 1 QDa 3: SIR Ch1 cAG 4.952 7011858 1956642 2 5 S0.1 1 QDa 3: SIR Ch1 cAG 4.984 1325278 288552 2 6 S0.5 1 QDa 3: SIR Ch1 cAG 4.959 4591557 1284336 3 7 S1 1 QDa 3: SIR Ch1 cAG 4.976 12841247 3512816 3 8 S1 1 QDa 3: SIR Ch1 cAG 4.950 8556273 2419111 4 9 S2 1 QDa 3: SIR Ch1 cAG 4.971 22678066 6025654 4 10 S2 1 QDa 3: SIR Ch1 cAG 4.957 16688228 4647724 5 11 S5 1 QDa 3: SIR Ch1 cAG 4.953 47041133 11956763 5 12 S5 1 QDa 3: SIR Ch1 cAG 4.947 34337876 9210881 6 13 S10 1 QDa 3: SIR Ch1 cAG 4.941 79070294 19204559 6 14 SST 5 1 QDa 3: SIR Ch1 cAG 4.999 39542480 10271494 6 15 S10 1 QDa 3: SIR Ch1 cAG 4.947 59384093 14956552 7 16 S20 1 QDa 3: SIR Ch1 cAG 4.947 130506901 29090130 7 Reported by User: System Report Method: Report Report Method ID: 1567 Page: 1 of 5 1 Project Name: Peptan and Active Peptides\Cyclic Peptides Date Printed: 7/15/2024 8:27:15 AM Europe/Brussels Component Summary Table Name: cAG SampleName Inj Channel Name RT Area Height Amount Units Vial 17 S40 1 QDa 3: SIR Ch1 cAG 4.968 203862980 40912123 8 18 S20 1 QDa 3: SIR Ch1 cAG 4.958 97863279 23121120 8 19 S60 1 QDa 3: SIR Ch1 cAG 4.948 265565647 50597603 9 20 S40 1 QDa 3: SIR Ch1 cAG 4.963 156626006 34028124 9 21 S60 1 QDa 3: SIR Ch1 cAG 4.952 206084286 42537895 10 22 S80 1 QDa 3: SIR Ch1 cAG 4.943 317230272 57355103 10 23 mQ 1 QDa 3: SIR Ch1 cAG 4.994 261552748 49920223 11 24 S80 1 QDa 3: SIR Ch1 cAG 4.966 248641458 48020731 11 25 S100 1 QDa 3: SIR Ch1 cAG 4.940 353658948 62771668 11 26 mQ 1 QDa 3: SIR Ch1 cAG 4.991 35641 12 27 S100 1 QDa 3: SIR Ch1 cAG 4.961 289109048 53993380 12 28 H539 1 QDa 3: SIR Ch1 cAG 5.090 71947 16372 12 29 MQ 1 QDa 3: SIR Ch1 cAG 4.988 171849 23944 13 30 H28x 1 QDa 3: SIR Ch1 cAG 5.004 11082745 1434313 13 31 H28x 2 QDa 3: SIR Ch1 cAG 4.945 9706503 1255662 13 32 H278 1 QDa 3: SIR Ch1 cAG 4.937 12722319 1246382 14 33 H544 1 QDa 3: SIR Ch1 cAG 4.941 10782480 1211408 14 34 H279 1 QDa 3: SIR Ch1 cAG 4.869 10765807 1154091 15 35 H547 1 QDa 3: SIR Ch1 cAG 4.833 3912815 681909 15 36 H280 1 QDa 3: SIR Ch1 cAG 4.875 7270274 820326 16 37 H547 1 QDa 3: SIR Ch1 cAG 4.986 160017 19421 16 38 H281 1 QDa 3: SIR Ch1 cAG 4.857 11306090 1256523 17 39 H282 1 QDa 3: SIR Ch1 cAG 4.860 10538915 921795 18 40 H283 1 QDa 3: SIR Ch1 cAG 4.936 9141598 866872 19 41 H290 1 QDa 3: SIR Ch1 cAG 4.858 11096164 1124069 20 42 H332 1 QDa 3: SIR Ch1 cAG 4.969 6022202 717798 21 43 mQ 1 QDa 3: SIR Ch1 cAG 4.987 281544 52153 22 44 H336 1 QDa 3: SIR Ch1 cAG 4.966 10691299 1252551 23 45 H337 1 QDa 3: SIR Ch1 cAG 4.976 12375805 1594623 24 46 H339 1 QDa 3: SIR Ch1 cAG 4.975 1835689 136763 25 47 H340 1 QDa 3: SIR Ch1 cAG 4.958 7254223 969476 26 48 H341 1 QDa 3: SIR Ch1 cAG 4.952 5627083 522527 27 49 H343 1 QDa 3: SIR Ch1 cAG 4.977 13296934 1424679 28 50 H352 1 QDa 3: SIR Ch1 cAG 4.972 1769372 375587 29 51 H366 1 QDa 3: SIR Ch1 cAG 4.897 3349823 404887 30 52 H377 1 QDa 3: SIR Ch1 cAG 4.980 11171736 1342570 31 53 H378 1 QDa 3: SIR Ch1 cAG 4.989 7324877 770167 32 54 mQ 1 QDa 3: SIR Ch1 cAG 4.784 50714 7313 33 Reported by User: System Report Method: Report Report Method ID: 1567 Page: 2 of 5 313059 Project Name: Peptan and Active Peptides\Cyclic Peptides Date Printed: 7/15/2024 8:27:15 AM Europe/Brussels Component Summary Table Name: cAG SampleName Inj Channel Name RT Area Height Amount Units Vial 55 H379 1 QDa 3: SIR Ch1 cAG 4.978 13965967 1591894 34 56 H380 1 QDa 3: SIR Ch1 cAG 4.976 8001179 977675 35 57 H382 1 QDa 3: SIR Ch1 cAG 4.947 14026392 2067666 36 58 H383 1 QDa 3: SIR Ch1 cAG 4.945 14240912 2114819 37 59 H384 1 QDa 3: SIR Ch1 cAG 4.970 15680158 2138450 38 60 H385 1 QDa 3: SIR Ch1 cAG 4.976 15665766 2164117 39 61 H386 1 QDa 3: SIR Ch1 cAG 4.785 1749267 247750 40 62 H387 1 QDa 3: SIR Ch1 cAG 4.847 5369859 509968 41 63 P2000 LD 2124687 1 QDa 3: SIR Ch1 cAG 4.954 7338364 1528585 42 64 P2000 LD 2124687 1 QDa 3: SIR Ch1 cAG 4.852 279933 24289 42 65 P5000 HD 2051964 1 QDa 3: SIR Ch1 cAG 4.940 2496629 596953 43 66 P5000 HD 2051964 1 QDa 3: SIR Ch1 cAG 4.943 2648798 615449 43 67 mQ 1 QDa 3: SIR Ch1 cAG 4.984 192804 26863 44 68 P2000 HD 2805833 1 QDa 3: SIR Ch1 cAG 4.954 9817013 1950697 45 69 P5000 LD 2332542 1 QDa 3: SIR Ch1 cAG 4.949 3614979 870274 46 70 P2000 HD 2652410 1 QDa 3: SIR Ch1 cAG 4.943 8069634 1676646 47 71 P2000 LD 2801910 1 QDa 3: SIR Ch1 cAG 4.934 8204498 1693333 48 72 P5000 LD 2493285 1 QDa 3: SIR Ch1 cAG 4.903 166576 17297 49 73 B2000 HD 2857163 1 QDa 3: SIR Ch1 cAG 4.954 5159218 1020042 50 74 B5000 HD 2857456 1 QDa 3: SIR Ch1 cAG 4.949 3585590 829088 51 75 B5000 LD 2748854 1 QDa 3: SIR Ch1 cAG 4.946 2687862 605872 52 76 B2000 LD 2826796 1 QDa 3: SIR Ch1 cAG 4.956 5194740 918316 53 77 B2000 LD 2826796 1 QDa 3: SIR Ch1 cAG 5.007 248170 30190 54 78 mQ 1 QDa 3: SIR Ch1 cAG 4.981 216682 29938 55 79 H388 1 QDa 3: SIR Ch1 cAG 4.944 9734587 1446013 68 80 H393 1 QDa 3: SIR Ch1 cAG 4.941 14738429 1932293 69 81 H394 1 QDa 3: SIR Ch1 cAG 4.940 14964179 1928656 70 82 H395 1 QDa 3: SIR Ch1 cAG 4.924 14798325 1910475 71 83 H396 1 QDa 3: SIR Ch1 cAG 4.942 14885759 1945588 72 84 H397 1 QDa 3: SIR Ch1 cAG 4.890 2739054 332832 73 85 H398 1 QDa 3: SIR Ch1 cAG 4.955 15362801 1953637 74 86 H399 1 QDa 3: SIR Ch1 cAG 4.934 14534756 1868162 75 87 H400 1 QDa 3: SIR Ch1 cAG 4.949 10194558 1745063 76 88 H401A 1 QDa 3: SIR Ch1 cAG 4.965 15093903 1863005 77 89 mQ 1 QDa 3: SIR Ch1 cAG 5.026 283390 31607 78 90 H401B 1 QDa 3: SIR Ch1 cAG 4.949 10253185 1803696 79 91 H402A 1 QDa 3: SIR Ch1 cAG 4.940 1630329 251374 80 92 H402B 1 QDa 3: SIR Ch1 cAG 4.811 15016259 1670432 81 Reported by User: System Report Method: Report Report Method ID: 1567 Page: 3 of 5 Project Name: Peptan and Active Peptides\Cyclic Peptides Date Printed: 7/15/2024 8:27:15 AM Europe/Brussels Component Summary Table Name: cAG SampleName Inj Channel Name RT Area Height Amount Units Vial 93 H403 1 QDa 3: SIR Ch1 cAG 4.937 1602042 253519 82 94 H404 1 QDa 3: SIR Ch1 cAG 4.823 3543994 321664 83 95 H406 1 QDa 3: SIR Ch1 cAG 4.925 11691618 1056947 84 96 H407 1 QDa 3: SIR Ch1 cAG 4.938 1644533 250402 85 97 H423A 1 QDa 3: SIR Ch1 cAG 4.957 6345347 1192211 86 98 H424A 1 QDa 3: SIR Ch1 cAG 4.830 4567987 475732 87 99 H425A 1 QDa 3: SIR Ch1 cAG 4.817 11135833 1116998 88 100 mQ 1 QDa 3: SIR Ch1 cAG 4.986 239840 35943 89 101 H426A 1 QDa 3: SIR Ch1 cAG 4.823 8939615 996060 90 102 H428A 1 QDa 3: SIR Ch1 cAG 4.816 8697631 1012546 91 103 H428B 1 QDa 3: SIR Ch1 cAG 4.941 9778277 1172849 92 104 H429A 1 QDa 3: SIR Ch1 cAG 4.809 11596623 1192805 93 105 H430A 1 QDa 3: SIR Ch1 cAG 4.869 6406692 731171 94 106 H431A 1 QDa 3: SIR Ch1 cAG 4.804 11135413 1126846 95 107 H433A 1 QDa 3: SIR Ch1 cAG 4.820 10402788 1158758 96 108 H423B 1 QDa 3: SIR Ch1 cAG 4.904 1501165 148341 97 109 H424B 1 QDa 3: SIR Ch1 cAG 4.951 3044223 536442 98 110 H425B 1 QDa 3: SIR Ch1 cAG 4.936 8000748 1454123 99 111 mQ 1 QDa 3: SIR Ch1 cAG 4.973 240045 25521 100 112 H426B 1 QDa 3: SIR Ch1 cAG 4.744 1613724 211679 101 113 H434A 1 QDa 3: SIR Ch1 cAG 4.791 9388635 1100812 102 114 H435A 1 QDa 3: SIR Ch1 cAG 4.810 4536279 565910 103 115 H436A 1 QDa 3: SIR Ch1 cAG 4.847 13750173 1269343 104 116 H437A 1 QDa 3: SIR Ch1 cAG 4.811 6674117 715491 105 117 H438A 1 QDa 3: SIR Ch1 cAG 4.854 7062368 838368 106 118 H440A 1 QDa 3: SIR Ch1 cAG 4.851 4067503 423051 107 119 H441A 1 QDa 3: SIR Ch1 cAG 4.845 3381558 311611 108 120 H442 1 QDa 3: SIR Ch1 cAG 4.955 2783795 253860 109 121 H455/454 1 QDa 3: SIR Ch1 cAG 4.797 9104421 954692 110 122 mQ 1 QDa 3: SIR Ch1 cAG 4.976 188836 28079 111 123 H529 1 QDa 3: SIR Ch1 cAG 4.796 2847017 272739 112 124 H530 1 QDa 3: SIR Ch1 cAG 4.965 2775048 225399 113 125 H532 1 QDa 3: SIR Ch1 cAG 4.787 9701112 1153541 114 126 H533 1 QDa 3: SIR Ch1 cAG 4.794 2128326 247287 115 127 H534 1 QDa 3: SIR Ch1 cAG 4.789 8103834 978485 116 128 H535 1 QDa 3: SIR Ch1 cAG 4.795 7916109 897486 117 129 H536 1 QDa 3: SIR Ch1 cAG 4.806 2429010 233928 118 130 H537 1 QDa 3: SIR Ch1 cAG 4.833 8380165 1035827 119 Reported by User: System Report Method: Report Report Method ID: 1567 Page: 4 of 5 Project Name: Peptan and Active Peptides\Cyclic Peptides Date Printed: 7/15/2024 8:27:15 AM Europe/Brussels Component Summary Table Name: cAG SampleName 131 H538 Mean Std. Dev. Inj Channel Name RT Area Height 1 QDa 3: SIR Ch1 cAG 4.790 5189928 592912 27615892 5164186 Vial 120 66437492 12816585 % RSD Reported by User: System Report Method: Report Report Method ID: 1567 Page: 5 of 5 Amount Units 240.6 Project Name: 248.2 Peptan and Active Peptides\Cyclic Peptides Date Printed: 7/15/2024 8:27:15 AM Europe/Brussels